Neuland Laboratories Limited (NSE:NEULANDLAB)
India · Delayed Price · Currency is INR 16,209
-234 (-1.42%)
Oct 21, 2025, 2:44 PM IST
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 210.58 billion as of October 21, 2025. Its market cap has increased by 36.98% in one year.
Market Cap
210.58B
Enterprise Value
209.76B
Revenue
13.30B
Ranking
n/a
PE Ratio
119.56
Stock Price
16,209.00
Market Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 210.58B, an increase of 62,734.73%. That is a compound annual growth rate of 29.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 208.24B | 18.23% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | 14.04B | 161.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.05T |
| Divi's Laboratories | 1.76T |
| Cipla | 1.27T |
| Apollo Hospitals Enterprise | 1.14T |
| Mankind Pharma | 1.02T |
| Zydus Lifesciences | 993.81B |
| Fortis Healthcare | 819.05B |
| Alkem Laboratories | 667.35B |